Ophthalmology

Top Story

Gene therapy progresses through efforts of small companies, attracts big investments

September 4, 2015

BARCELONA — Gene therapy has greatly progressed in rare disorders, such as Leber’s congenital amaurosis, but several applications are under evaluation and show promise, according to Jose-Alain Sahel, MD, who chaired a symposium on the topic at the Ophthalmology Futures European Forum.

“Gene therapy has also been tested as a novel form of drug delivery to the retina for AMD with anti-VEGFs. Results are so far not perfectly convincing, but there is a rationale to continue research in this direction,” he said.

Meeting News Coverage

Ophthalmic market enjoys favorable trend, attracts investors

September 4, 2015
BARCELONA — The future looks bright for the ophthalmic industry, which currently enjoys a very favorable trend, according to one speaker at the Ophthalmology…
Meeting News Coverage

SalutarisMD receives FDA clearance for radionuclide brachytherapy source

September 4, 2015
BARCELONA — Salutaris Medical Devices has received 510(k) clearance from FDA for its SMD Sr90-1 radionuclide brachytherapy source, according to a press release.The…
Breaking News

Allergan to acquire AqueSys

September 4, 2015
Allergan will acquire AqueSys in an all cash transaction of $300 million, the company announced in a press release. Under the terms of the agreement, the upfront payment…
Speaker: Ophthalmologists need to learn more about microbes Meeting News Coverage

Speaker: Ophthalmologists need to learn more about microbes

September 4, 2015
BARCELONA — Ophthalmologists need to learn more about microbes in order to better treat and understand ocular infections, according to a speaker. “We need…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »
Vitreomacular Adhesion

Vitreomacular Adhesion: Addressing Patient Selection and Safety Concerns for Optimal Treatment

This activity is supported by an educational grant from ThromboGenics.

Clinicians gained a new option for the management of vitreomacular adhesion in 2012 with the FDA approval of a…
More »
Meeting News Coverage Video
VIDEO: Defining and treating astigmatism

VIDEO: Defining and treating astigmatism

July 26, 2015
At the Kiawah Eye 2015 meeting, John A. Hovanesian, MD, FACS, discusses how treating astigmatism in patients will…
More »
morganatic-roan